DAVID POPLACK to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications DAVID POPLACK has written about Antimetabolites, Antineoplastic.
Connection Strength
0.364
-
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.
Score: 0.154
-
Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
Score: 0.075
-
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
Score: 0.054
-
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77.
Score: 0.035
-
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7.
Score: 0.032
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.009
-
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31.
Score: 0.005